Parkside Financial Bank & Trust’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.07K | Buy |
34
+19
| +127% | +$600 | ﹤0.01% | 2239 |
|
2025
Q1 | $492 | Buy |
+15
| New | +$492 | ﹤0.01% | 2401 |
|
2023
Q4 | – | Sell |
-183
| Closed | -$5.05K | – | 2174 |
|
2023
Q3 | $5.05K | Buy |
183
+15
| +9% | +$414 | ﹤0.01% | 1363 |
|
2023
Q2 | $5.05K | Hold |
168
| – | – | ﹤0.01% | 1366 |
|
2023
Q1 | $6.09K | Hold |
168
| – | – | ﹤0.01% | 1286 |
|
2022
Q4 | $5.99K | Hold |
168
| – | – | ﹤0.01% | 1246 |
|
2022
Q3 | $6K | Hold |
168
| – | – | ﹤0.01% | 1175 |
|
2022
Q2 | $5K | Sell |
168
-4
| -2% | -$119 | ﹤0.01% | 1261 |
|
2022
Q1 | $6K | Buy |
172
+4
| +2% | +$140 | ﹤0.01% | 1248 |
|
2021
Q4 | $5K | Buy |
168
+4
| +2% | +$119 | ﹤0.01% | 1346 |
|
2021
Q3 | $4K | Sell |
164
-16
| -9% | -$390 | ﹤0.01% | 1363 |
|
2021
Q2 | $6K | Buy |
180
+16
| +10% | +$533 | ﹤0.01% | 1186 |
|
2021
Q1 | $4K | Hold |
164
| – | – | ﹤0.01% | 1307 |
|
2020
Q4 | $4K | Buy |
164
+136
| +486% | +$3.32K | ﹤0.01% | 1221 |
|
2020
Q3 | $1K | Sell |
28
-16
| -36% | -$571 | ﹤0.01% | 1430 |
|
2020
Q2 | $1K | Buy |
44
+22
| +100% | +$500 | ﹤0.01% | 1386 |
|
2020
Q1 | $0 | Sell |
22
-55
| -71% | – | ﹤0.01% | 1644 |
|
2019
Q4 | $2K | Buy |
77
+29
| +60% | +$753 | ﹤0.01% | 1244 |
|
2019
Q3 | $1K | Buy |
+48
| New | +$1K | ﹤0.01% | 1449 |
|
2019
Q2 | – | Sell |
-54
| Closed | -$2K | – | 1667 |
|
2019
Q1 | $2K | Buy |
54
+11
| +26% | +$407 | ﹤0.01% | 1208 |
|
2018
Q4 | $1K | Buy |
43
+9
| +26% | +$209 | ﹤0.01% | 1321 |
|
2018
Q3 | $2K | Hold |
34
| – | – | ﹤0.01% | 1133 |
|
2018
Q2 | $2K | Buy |
34
+3
| +10% | +$176 | ﹤0.01% | 1105 |
|
2018
Q1 | $1K | Hold |
31
| – | – | ﹤0.01% | 1288 |
|
2017
Q4 | $1K | Hold |
31
| – | – | ﹤0.01% | 1226 |
|
2017
Q3 | $1K | Hold |
31
| – | – | ﹤0.01% | 1227 |
|
2017
Q2 | $1K | Hold |
31
| – | – | ﹤0.01% | 1252 |
|
2017
Q1 | $1K | Hold |
31
| – | – | ﹤0.01% | 1213 |
|
2016
Q4 | $1K | Buy |
+31
| New | +$1K | ﹤0.01% | 1209 |
|